MicroRNA 218 acts
as a tumor suppressor by targeting multiple cancer phenotype - associated genes in medulloblastoma.
Not exact matches
A study in this week's Neuron provides key evidence that DNA methylation — also known to occur
as cancerous cells divide, when
tumor suppressor genes are silenced — occurs in adult brains and can be triggered
by environmental cues.
A neuro - oncology research team at Dartmouth's Norris Cotton Cancer Center, led
by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4
as a
suppressor of
tumor cell invasion in glioblastoma.
By searching for gene deletion patterns in cancer through a concept the investigators call «synthetic essentiality,» the team identified a synthetic essential gene known
as chromatin helicase DNA - binding factor (CHD1)
as a therapeutic target for prostate and breast cancers lacking a
tumor suppressor gene called phosphatase and tensin homolog (PTEN).
After the KRAS mutation was induced
by the researchers, other mutations in what are known
as tumor suppressor genes developed.
«This function for BAI1 may have implications for cancer biology, since MDM2 can function
as an oncogene
by degrading important
tumor suppressors like p53.»
Now, results of a new study
by Johns Hopkins Kimmel Cancer Center scientists suggests a powerful role for the protein in normal breast cells, acting
as a
tumor suppressor that halts abnormal cell growth.
In fact, KLF4 blocks senescence and apoptosis
by repressing transcription of P53, whereas it can activate P21 - dependent cell - cycle arrest, and therefore, KLF4 can function both
as a
tumor suppressor and an oncogene (33, 34).
On the other hand, aberrant expression of miR - 7 was observed in glioblastomas, and it has been characterized
as a putative
tumor suppressor by targeting EGFR and AKT (23, 24).
Synthetic lethality - based strategy has been developed to identify therapeutic targets in cancer harboring
tumor suppressor gene mutations,
as exemplified
by the effectiveness of PARP inhibitors in BRCA1 / 2 - mutated
tumors.
LKB1, originally identified
as a
tumor suppressor protein, is currently thought
as a critical regulator of cellular metabolism and growth
by controlling the activity of AMP - activated protein kinase (AMPK) and also 12 other kinases that are closely related to AMPK.
Here, we have used a genetic approach to address the function of RASSF1A
as a
tumor suppressor in vivo
by targeted deletion of Rassf1A in the mouse.
LA JOLLA, CA — A collaborative study
by researchers at the Salk Institute for Biological Studies uncovered that the
tumor suppressor p53, which made its name
as «guardian of the genome,» not...
We validated ZBTB20, CELF2, PARD3, AKAP13 and WAC, which were identified
by our screens in multiple cancer types,
as new
tumor suppressor genes in prostate cancer.
On the one hand, autophagy functions
as a
tumor suppressor mechanism
by preventing the accumulation of damaged organelles and aggregated proteins.